magneticvc.com
Open in
urlscan Pro
104.196.15.87
Public Scan
Submitted URL: http://magneticvc.com/
Effective URL: https://magneticvc.com/
Submission: On October 19 via api from US — Scanned from DE
Effective URL: https://magneticvc.com/
Submission: On October 19 via api from US — Scanned from DE
Form analysis
1 forms found in the DOMGET https://magneticvc.com/
<form role="search" method="get" class="et-search-form" action="https://magneticvc.com/">
<input type="search" class="et-search-field" placeholder="Search …" value="" name="s" title="Search for:">
</form>
Text Content
* About * Team * Portfolio * News * Contact Select Page * About * Team * Portfolio * News * Contact WE HELP VISIONARY FOUNDERS BUILD CATEGORY-DEFINING HEALTHCARE COMPANIES. We are driven by respect for the bold entrepreneurs who wake up every morning with the same goal as Magnetic – to improve patients’ lives. With more than 25 years of multifaceted experience at large pharmaceutical and diagnostic companies, start-ups, and as investors, we respect the company building process and are here for our founders, every step of the way. WE UNDERSTAND THE COMPLEX WORLD OF HEALTHCARE. With regulatory and market dynamics unique to the sector, we know how to navigate these complexities and understand the entire lifecycle of healthcare – from discovery, to regulatory, through commercialization. During our decades in the industry, we’ve sat in FDA meetings, negotiated business development deals, and have launched and scaled some of the most ground-breaking technologies and companies in the sector. PORTFOLIO View Our Portfolio › Using active-graph machine learning (ML) combined with single-cell analysis to advance therapeutic candidates for diseases with no or few good medicines. Unlocking the potential of microfluidics and machine learning to discover modulators of biomolecular condensates in human disease. Using cellular barcoding technology to transform clinical decision making in oncology patients. Changing the way complex medicines are made and distributed through technology innovation Improving healthcare for minority patients through technology-based patient engagement solutions Using AI to rapidly accelerate drug discovery and development for rare genetic diseases IN THE NEWS View All › ENDPOINTS NEWS 08.15.22 RESILIENCE COLLABORATES WITH THE MAYO CLINIC TO MANUFACTURE RARE AND COMPLEX DISEASE DRUGS ENDPOINTS NEWS 06.09.22 EXCLUSIVE: PFIZER VET GRABS $25M SEED ROUND TO ‘INTEGRATE’ MACHINE LEARNING, GENOMICS TECH IN DRUG R&D (RELATION THERAPEUTICS) ENDPOINTS NEWS 06.08.22 RESILIENCE NETS ANOTHER DEAL, THIS TIME WITH BILLIONAIRE’S CANCER RESEARCH CENTER BLOOMBERG 06.06.22 RESILIENCE ANNOUNCES $625 MILLION SERIES D FINANCING TO EXPAND NETWORK, BRING INNOVATIVE TECHNOLOGIES TO BIOMANUFACTURING ENDPOINTS NEWS 06.02.22 THE TARGET IS THE SYSTEM: CONDENSATES BIOTECH ASPIRES TO ‘REWRITE THE RULEBOOK’ ON DRUG DISCOVERY (TRANSITION BIO) * Home * About * Team * Portfolio * News * Contact ©2022 Magnetic Ventures. All rights reserved.